NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
14 March 2025
| Name: | PHOSPHAGENICS LIMITED (POH) (This company subsequently changed its name to AVECHO BIOTECHNOLOGY LIMITED. You should refer to that name for Status.) | |||||||||
| Date of Listing: | 09 August 1993 | |||||||||
| Subsequent Names: |
| |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to AVECHO BIOTECHNOLOGY LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to AVECHO BIOTECHNOLOGY LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now AVECHO BIOTECHNOLOGY LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| AVECHO BIOTECHNOLOGY LIMITED | 27/05/2019 | |
| PHOSPHAGENICS LIMITED | 10/02/2004 | 27/05/2019 |
| VITAL CAPITAL LIMITED | 27/04/1999 | 10/02/2004 |
| GREENCHIP DEVELOPMENT CAPITAL LIMITED | 27/04/1999 |
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Avecho Biotechnology Limited | 27/05/2019 |
The company announces that a full and final settlement of all claims associated with the arbitration has been successfully negotiated with Phosphagenics (POH), Mylan Laboratories Ltd (Mylan) and Strides Pharma Asia PTE Limited (Strides) | 19/12/2018 |
The suspension of trading in the securities of Phosphagenics Limited ("˜POH') will be lifted immediately, following the release of an announcement by the Company. | 19/12/2018 |
The company is continuing with advanced negotiations with Mylan in relation to the quantum of costs that might be payable under the arbitration and future arrangements for commercialisation of the intellectual property that has been under dispute. Accordingly the Company will remain in trading suspension until it announces finalisation of the agreements which are expected to be concluded by 14 December 2018. | 13/12/2018 |
The securities of Phosphagenics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of POH, pending the release of an announcement regarding Mylan arbitration cost negotiations. | 12/12/2018 |
name changed from Vital Capital Limited | 10/02/2004 |
name changed to Avecho Biotechnology Limited | 27/05/2019 |
The company announces that a full and final settlement of all claims associated with the arbitration has been successfully negotiated with Phosphagenics (POH), Mylan Laboratories Ltd (Mylan) and Strides Pharma Asia PTE Limited (Strides) | 19/12/2018 |
The suspension of trading in the securities of Phosphagenics Limited ("˜POH') will be lifted immediately, following the release of an announcement by the Company. | 19/12/2018 |
The company is continuing with advanced negotiations with Mylan in relation to the quantum of costs that might be payable under the arbitration and future arrangements for commercialisation of the intellectual property that has been under dispute. Accordingly the Company will remain in trading suspension until it announces finalisation of the agreements which are expected to be concluded by 14 December 2018. | 13/12/2018 |
The securities of Phosphagenics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of POH, pending the release of an announcement regarding Mylan arbitration cost negotiations. | 12/12/2018 |
name changed from Vital Capital Limited | 10/02/2004 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 02/03/2017 | David Segal | 500,000 | $0.020 | $10,000 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Greg Collier | Non Exec Chairman | 13/04/2015 |
| Melanie Leydin | CFO, Company Secretary | 28/12/2018 |
| David Segal | Non Exec Director | 19/05/2016 |
| Ross Murdoch | Non Exec Director | 14/01/2015 |
| Harry Rosen | Director | 07/06/1999 |
| Michael Sapountzis | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Anna Legg | CFO | 22/01/2013 | 24/12/2018 |
| Peter Lankau | Independent Director | 13/04/2015 | 25/05/2018 |
| Geert Cauwenbergh | Independent Director | 03/03/2014 | 30/05/2017 |
| Nathan Drona | Independent Director | 03/03/2014 | 18/05/2016 |
| Lawrence Gozlan | Non Exec Chairman, Independent Director | 03/03/2014 | 12/05/2015 |
| Jonathan Addison | Chairman, Non Exec Director | 19/11/2002 | 03/03/2014 |
| Sandra Webb | Non Exec Director | 24/08/2010 | 03/03/2014 |
| Don Clarke | Non Exec Director | 24/08/2010 | 03/03/2014 |
| Stuart James | Non Exec Director | 24/08/2010 | 03/03/2014 |
| Esra Ogru | CEO, Executive Director | 11/10/2005 | 18/07/2013 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
